| 000 | 00994 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516122116.0 | ||
| 264 | 0 | _c20210211 | |
| 008 | 202102s 0 0 eng d | ||
| 022 | _a2162-4011 | ||
| 024 | 7 |
_a10.4161/onci.20931 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVacchelli, Erika | |
| 245 | 0 | 0 |
_aTrial watch: FDA-approved Toll-like receptor agonists for cancer therapy. _h[electronic resource] |
| 260 |
_bOncoimmunology _cSep 2012 |
||
| 300 |
_a894-907 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 700 | 1 | _aGalluzzi, Lorenzo | |
| 700 | 1 | _aEggermont, Alexander | |
| 700 | 1 | _aFridman, Wolf Hervé | |
| 700 | 1 | _aGalon, Jerome | |
| 700 | 1 | _aSautès-Fridman, Catherine | |
| 700 | 1 | _aTartour, Eric | |
| 700 | 1 | _aZitvogel, Laurence | |
| 700 | 1 | _aKroemer, Guido | |
| 773 | 0 |
_tOncoimmunology _gvol. 1 _gno. 6 _gp. 894-907 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/onci.20931 _zAvailable from publisher's website |
| 999 |
_c22274429 _d22274429 |
||